Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarkers Predicting Postimplantation Syndrome After Endovascular Aortic Repair (EVAR) and Thoracic Endovascular Aortic Repair (TEVAR)

NCT07014839 is registered in ClinicalTrials.gov with Ataturk University as lead sponsor.

NCT NCT07014839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07014839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarkers Predicting Postimplantation Syndrome After Endovascular Aortic Repair (EVAR) and Thoracic Endovascular Aortic Repair (TEVAR)
Lead sponsor
Ataturk University
Phase
Observational
Overall status
Completed
Start date
January 1, 2018
Completion date
April 15, 2025
Enrollment
300 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

endovascular abdominal aortic aneurysm repair (evar), postimplantation syndrome, thoracic endovascular aortic repair